Article

Pan-cancer Proteomics Analysis to Identify Tumor-Enriched and Highly Expressed Cell Surface Antigens as Potential Targets for Cancer Therapeutics

2023-01-23

Abstract excerpt

<h4>ABSTRACT</h4> The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) provides unique opportunities for cancer target discovery using protein expression. Proteomics data from CPTAC tumor types have been primarily generated using a multiplex tandem mass tag (TMT) approach, which is designed to provide protein quantification relative to reference samples. However, relative protein e...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a9bef2dc-334d-5695-8109-e36d8d703d54
DOI: 10.1101/2023.01.23.525265

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Pan-cancer Proteomics Analysis to Identify Tumor-Enriched and Highly Expressed Cell Surface Antigens as Potential Targets for Cancer TherapeuticsDOI 10.1101/2023.01.23.525265Read

Pan-Cancer Proteomics Analysis to Identify Tumor-Enriched and Highly Expressed Cell Surface Antigens as Potential Targets for Cancer TherapeuticsSemantic proximity Read

Pan-cancer proteogenomics expands the landscape of therapeutic targetsSemantic proximity Read

Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancersSemantic proximity Read

The Target Atlas for Antibody-Drug Conjugates across Solid CancersSemantic proximity Read

Integration of proteomics in the molecular tumor boardSemantic proximity Read

TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissuesSemantic proximity Read

High‐throughput and multi‐phases identification of autoantibodies in diagnosing early‐stage breast cancer and subtypesSemantic proximity Read

A Multi-Layered Proteogenomic Framework for Prioritization of Cell Surface Therapeutic Targets in Solid TumorsSemantic proximity Read

Profiling Protein Post-Translational Modifications in Plasma-derived Extracellular Vesicles as Fingerprints for Breast Cancer SubtypesSemantic proximity Read

High-density, targeted monitoring of tyrosine phosphorylation reveals activated signaling networks in human tumorsSemantic proximity Read

The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targetsSemantic proximity Read

Multi-omics analysis identifies BCAT2 as a potential pan-cancer biomarker for tumor progression and immune microenvironment modulationSemantic proximity Read